Mechanism of Increased Fluconazole Resistance in Candida glabrata during Prophylaxis

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 5, 2004, Pages 1773-1777

  Bennett, John E ^a,c   Izumikawa, Koichi ^a   Marr, Kieren A ^b  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; FLUCONAZOLE; RHODAMINE 6G;

ANTIBIOTIC RESISTANCE; ARTICLE; CANDIDA GLABRATA; CELL INVASION; COLONY FORMATION; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG EXPOSURE; DRUG TRANSPORT; GENETIC TRANSCRIPTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; KARYOTYPE; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OROPHARYNX; PRIORITY JOURNAL; PROPHYLAXIS;

ANTIFUNGAL AGENTS; BLOTTING, NORTHERN; CANDIDA GLABRATA; CANDIDIASIS; DRUG RESISTANCE, FUNGAL; DRUG RESISTANCE, MULTIPLE, FUNGAL; ELECTROPHORESIS, GEL, PULSED-FIELD; FLUCONAZOLE; FLUORESCENT DYES; KARYOTYPING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHODAMINES;

EID: 2142810157     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.5.1773-1777.2004     Document Type: Article

References (21)

1. Asakura, K., S. I. Iwaguchi, M. Homma, T. Suae, K. Higashide, and K. Tanaka. 1991. Electrophoretic karyotypes of clinically isolated yeasts of Candida albicans and C. glabrata. J. Gen. Microbiol. 137:2531-2538.
2. Ausuhel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl. 1998. Current protocols in molecular biology. John Wiley & Sons, Somerset, N.J.
3. Barchiesi, F., L. Falconi Di Francesco, D. Arzeni, F. Caselli, D. Gallo, and G. Scalise. 1999. Electrophoretic karyotyping and triazole susceptibility of Candida glabrata clinical isolates. Eur. J. Clin. Microbiol. Infect. Dis. 18:184-187.
4. Barchiesi, F., D. Arzeni, M. S. Del Prete, A. Sinicco, L. F. Di Fancesco, M. B. Pasticci, L. Lamura, M. M. Nuzzo, F. Burzacchini, S. Coppola, F. Chiodo, and F. Scalise. 1998. Fluconazole susceptibility and strain variation of Candida albicans isolates from HIV-infected patients with oropharyngeal candidosis. J. Antimicrob. Chemother. 41:541-548.
5. Clark, F. S., T. Parkinson, C. A. Hitchcock, and N. A. R. Gow. 1996. Correlation between rhodamine 123 accumulation and azole sensitivity in Candida species: possible role for drug efflux in resistance. Antimicrob. Agents Chemother. 40:419-425.
6. Guennec, R. L., J. Reynes, M. Mallié, C. Pujol, F. Janbon, and J.-M. Bastide. 1995. Fluconazole- and itraconazole-resistant Candida albicans strains from AIDS patients: multilocus enzyme electrophoresis analysis and antifungal susceptibilities. J. Clin. Microbiol. 33:2732-2737.
7. Hunter, P. R., and M. A. Gaston. 1988. Numerical index of the discriminatory ability of typing systems: an application of Simpson's index of diversity. J. Clin. Microbiol. 226:2465-2466.
8. Izumikawa, K., H. Kakeya, H.-F. Tsai, B. Grimberg, and J. E. Bennett. 2003. Function of Candida glabrata ABC transporter, PDH1. Yeast 20:249-261.
9. Kaufmann, C. S., and W. G. Merz. 1989. Electrophoretic karyotypes of Torulopsis glabrata. J. Clin. Microbiol. 27:2165-2168.
10. Khattak, M. N., J. P. Burnie, R. C. Matthews, and B. A. Oppenheim. 1992. Clamped homogeneous elective field typing of Torulopsis glabrata isolates causing nosocomial infections. J. Clin. Microbiol. 30:2211-2215.
11. Marr, K. A., T. White, J.-A. H. van Burik, and R. A. Bowden. 1997. Development of fluconazole resistance in Candida albicans causing disseminated infection in a patient undergoing bone marrow transplantation. Clin. Infect. Dis. 25:908-910.
12. Marr, K. A, C. N. Lyons, K. Ha, T. R. Rustad, and T. C. White. 2001. Inducible azole resistance associated with a heterogenous phenotype in Candida albicans. Antimicrob. Agents Chemother. 45:52-59.
13. Marr, K. A., K. Seidel, T. C. White, and R. A. Bowden. 2000. Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole. Clin. Infect. Dis. 181:309-316.
14. Millon, L., A. Manteaux, G. Reboux, C. Drobacheff, M. Monod, T. Barale, and R. Michel-Briand. 1994. Fluconazole-resistant recurrent oral candidiasis in human immunodeficiency virus-positive patients: persistence of Candida albicans strains with the same genotype. J. Clin. Microbiol. 32:1115-1118.
15. Miyazaki, H., Y. Miyazaki, A. Geber, T. Parkinson, C. Hitchcock, D. Falcone, K. Marsden, and J. E. Bennett. 1998. Fluconazole resistance associated with drug efflux and increased transcription of a drug transporter gene, PDH1, in Candida glabrata. Antimicrob. Agents Chemother. 42:1695-1701.
16. National Committee for Clinical Laboratory Standards. 1995. Reference method for broth dilution antifungal susceptibility testing of yeast. Approved standard M27-A. National Committee for Clinical Laboratory Standards, Wayne, Pa.
17. Parkinson, T., D. F. Falconer, and C. A. Hitchcock. 1995. Fluconazole resistance due to energy-dependent drug efflux in Candida glabrata. Antimicrob. Agents Chemother. 39:1696-1699.
18. Pfaller, M. A., S. A. Messer, R. J. Hollis, R. N. Jones, and J. D. Diekema. 2002. In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp. Antimicrob. Agents Chemother. 46:1723-1727.
19. Sanglard, D., and F. C. Odds. 2002. Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect. Dis. 2:73-85.
20. Sanglard, D., F. Ischer, D. Calahrese, P. A. Majcherczyk, and J. Bille. 1999. The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents. Antimicrob. Agents Chemother. 43:2753-2765.
21. Sanglard, D., K. Kuchler, F. Ischer, J.-L. Pagani, M. Monod, and J. Bille. 1995. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific drug transporters. Antimicrob. Agents Chemother. 39:2378-2386.